Merck KGaA (OTCMKTS:MKKGY) Sees Large Volume Increase – Time to Buy?

Merck KGaA (OTCMKTS:MKKGY) saw strong trading volume on Monday . 185,387 shares changed hands during mid-day trading, an increase of 157% from the previous session’s volume of 72,243 shares.The stock last traded at $30.70 and had previously closed at $29.94.

Merck KGaA Price Performance

The stock has a market capitalization of $19.85 billion, a P/E ratio of 12.24, a price-to-earnings-growth ratio of 6.09 and a beta of 0.95. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.97 and a current ratio of 1.49. The firm has a 50-day moving average price of $27.62 and a 200 day moving average price of $26.61.

Merck KGaA (OTCMKTS:MKKGY) last issued its earnings results on Thursday, November 13th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.27. Merck KGaA had a return on equity of 10.07% and a net margin of 13.92%.The business had revenue of $6.17 billion during the quarter, compared to analyst estimates of $6.08 billion. On average, analysts expect that Merck KGaA will post 1.87 EPS for the current year.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.